<!DOCTYPE html>

<html lang="en">
    <head>
        <title>Phase 2</title>
    </head>

    <body>
        <script src="../scripts/wiki.js"></script>
        <!-- <script src="/Template:Ionis_Paris/scripts/wiki?action=raw&ctype=text/javascript"></script> -->
        <div class="navigation"></div>
        <div class="tailwind"></div>
        <div id="phase3" x-data="{}" :style="'background-image: url(' + window.LINKS.phase2Logo.url + ')'">
            <div class="container">
                <h1>Bactails - IGEM IONIS</h1>
                <div class="phase3Content">
                    <div class="phase3Text">
                        <div class="phase3Text1">Phase 2</div>
                        <div class="phase3Text2">How to kill the target?</div>
                    </div>
                </div>
            </div>
        </div>
        <div class="seeMore" target-id="introduction"></div>
        <div id="introduction">
            <div class="container">
                <div class="lg:flex gap-16">
                    <div class="">
                        <div class="introductionTitle">Introduction</div>
                        <div class="mt-4 p-4 cardIntroduction">
                            Phase 2 is <b>killing the target</b> once the chassis has bound to it. For this we looked
                            into bacteriocins. Bacteriocins are <b>antimicrobial peptides</b> (AMP) naturally
                            synthetized by ribosomes and produced by bacteria to help them survive in a highly
                            competitive polymicrobial environment<sup>1</sup>. Bacteriocins are mostly synthetized by
                            Gram positive bacteria such as Lactic Acid Bacteria but Gram negatives can also secrete some
                            types of peptides. The first bacteriocin was identified in 1925<sup>2</sup>.
                        </div>
                        <div class="mt-4 p-4 cardIntroduction">
                            Interesting characteristics about bacteriocins that comforted our choice in using them for
                            our project is that they are considered as
                            <b>non-harmful for human</b> use as they are easily degraded by proteolytic enzymes and can
                            target specific pathogens in contrary to antibiotics so they do not have an impact on the
                            commensal flora, however there are some eventual exceptions<sup>1</sup>.
                        </div>
                        <div class="mt-4 p-4 cardIntroduction">
                            Research on bacteriocins to fight against human pathogens exists but most of the time they
                            are <b>combined with drugs</b>. For example, the well-known antibiotic resistant-pathogenic
                            <i>Pseudomonas aeruginosa</i> which, according to the Centers for Disease Control and
                            Prevention, was responsible for 2 700 in the USA in 2017, is sensitive to the bacteriocin
                            Nisin supplemented with Polymyxin E and Clarithromycin<sup>1</sup>.
                        </div>
                    </div>
                </div>
            </div>

            <div class="container">
                <div id="focus">
                    <div class="textFocus">
                        <div class="textFocus1Goal">
                            <div class="textFocus1GoalIconWrapper">
                                <i data-feather="eye"></i>
                            </div>
                            Our Focus for Bactail
                        </div>
                    </div>
                    <div id="#phase2Animate">
                        <div class="phase2Animation">
                            <div id="jk"></div>
                            <script type="module" defer>
                                const initAnim = async () => {
                                    const animLogoElm = document.getElementById("jk")

                                    while (!window.bodymovin) {
                                        await new Promise(res => setTimeout(res, 500))
                                    }

                                    const animation = bodymovin.loadAnimation({
                                        container: animLogoElm,
                                        renderer: "svg",
                                        autoplay: false,
                                        path: window.LINKS.phase2Animate.url,
                                        loop: false,
                                        assetsPath: "https://2020.igem.org/wiki/images",
                                    })

                                    let animStarted = false

                                    const startAnim = () => {
                                        if (animStarted) {
                                            return
                                        }

                                        const elmPos = animLogoElm.getBoundingClientRect().top
                                        const posFromMiddle = elmPos - window.innerHeight / 2

                                        if (posFromMiddle < 0) {
                                            animStarted = true
                                            animation.goToAndPlay(0)
                                        }
                                    }

                                    while (!window.rxjs) {
                                        await new Promise(res => setTimeout(res, 300))
                                    }

                                    const { Subject, interval } = rxjs
                                    const { throttle } = rxjs.operators

                                    window.scrollSource
                                        .pipe(
                                            throttle(() => interval(300), {
                                                leading: true,
                                                trailing: true,
                                            }),
                                        )
                                        .subscribe(startAnim)

                                    window.scrollSource.next()
                                }

                                initAnim()
                            </script>
                        </div>
                    </div>
                    <div class="focusContent textContent">
                        <p>
                            As mentioned previously, the proof of concept is conducted using <i>E. coli</i> K-12 Î”OmpC
                            as the chassis and <i>E. coli</i> K-12 or B as the target strain. Meaning that for the proof
                            of concept, we need to choose a bacteriocin that can
                            <b>kill the target but not the host</b>. There are many different types of bacteriocins with
                            various activity spectrums.
                        </p>
                        <div class="flex text-center mt-16 mb-16 justify-start">
                            <div class="targetText p-2 pl-4 pr-4">
                                <b>Microcins</b> are very small types of bacteriocins whose
                                <b>secretion is not lethal</b> to the <b>producing cell</b> in contrast to colicins
                                which are larger and cause membrane lysis of the producer strain<sup>1</sup>. Since our
                                final goal is to target antibiotic resistant bacteria, we looked into microcins
                                originally produced by <b>Gram negative</b> bacteria that had already been shown to have
                                an effect on these pathogens while also on the <i>E. coli</i> target of our proof of
                                concept<sup>1</sup>.
                            </div>
                        </div>
                        <div class="textBubble triggerMiddle fromRight">
                            <div class="textBubble1">
                                <div class="textBubbleIconWrapper">C,L & B17</div>
                                <i
                                    >Largest antibacterial spectrum. Target E. coli, Shigella spp., <br />Salmonella
                                    spp., Klebsiella spp., Pseudomonas spp.
                                </i>
                            </div>
                        </div>
                        <div class="textBubble triggerMiddle fromRight">
                            <div class="textBubble1">
                                <div class="textBubbleIconWrapper">E492</div>
                                <i
                                    >Narrower spectrum and targets E. coli, <br />Klebsiella pneumoniae, Salmonella
                                    enteritidis.</i
                                >
                            </div>
                        </div>
                        <div class="textBubble triggerMiddle fromRight">
                            <div class="textBubble1">
                                <div class="textBubbleIconWrapper">V</div>
                                <i>Against E. coli, but all Gram-negative bacteria are resistant.</i>
                            </div>
                        </div>
                        <div class="textBubble triggerMiddle fromRight">
                            <div class="textBubble1">
                                <div class="textBubbleIconWrapper">J25</div>
                                <i>Specifically against Salmonella and E. coli.</i>
                            </div>
                        </div>
                        <div class="textBubble triggerMiddle fromRight">
                            <div class="textBubble1">
                                <div class="textBubbleIconWrapper">S</div>
                                <i>
                                    Against P. aeruginosa and could inhibit <br />the adherence of enteropathogenic E.
                                    coli.</i
                                >
                            </div>
                        </div>
                    </div>
                </div>

                <div id="goals">
                    <div class="titleGoal flex items-center gap-4">
                        <div class="titleGoalIcon rounded-full flex items-center justify-center">
                            <i data-feather="check-circle"></i>
                        </div>
                        <div class="titleGoalText">Main goal(s)</div>
                    </div>
                    <div class="textContent mt-8 p-4">
                        <p>
                            The <b>initial goal</b> was to
                            <b>link the physical binding of the LTF to the target with the secretion of AMP</b>.
                            Meaning, the expression of the AMP would be induced once the bacteria bound. We looked into
                            shear stress (since there could be a mechanical signal when the LTF was bound),
                            reengineering two component systems etc. What was <b>difficult</b> was that the LTF was
                            linked to the outer membrane via Lpp-OmpA and that nothing could be expressed upstream of
                            the Lpp without affecting its outer membrane signaling function that we needed.
                        </p>
                    </div>

                    <div class="textContent mt-8 p-4">
                        <p>
                            After months of intense research and brainstorming on this concept we concluded that with
                            the remaining time we had, our initial objective could not be completed: The expression of
                            AMP had to be <b>constitutive</b> and it had to be controlled in a way that it would only
                            affect the target strain once the chassis is nearby. With that in mind, we found a microcin
                            called <b>MccPDI</b> (Proximity Dependent Inhibition) which was first identified in 2009<sup
                                >3</sup
                            >
                            and requires close <b>physical proximity</b> between the producer and susceptible strains.
                            MccPDI has a <b>narrow spectrum</b> and can kill several strains of <b><i>E. coli</i></b
                            >: multidrug resistant <i>E. coli</i>, enterotoxigenic <i>E. coli</i> expressing F5 (K99)
                            and F4 (K88) fimbriae, enterohemorrhagic <i>E. coli</i> O157:H7 and O26, as well as
                            commensal strains such as <i>E. coli</i> K12<sup>3</sup>3. It has also been shown that
                            Shigella is sensitive to MccPDI<sup>4</sup>. It recognizes specific Outer Membrane Protein F
                            motifs on the target and leads to <b>lethal membrane damage</b>. The MccPDI gene cluster was
                            initially identified in the strain <i>E. coli</i> 25 plasmid<sup>4</sup>. It is a locus of
                            approximately 4.8kb and is composed of 5 genes which are each necessary for the appropriate
                            expression, activity and secretion of microcin PDI.
                        </p>
                    </div>
                    <img x-data="{}" class="imgColiKaze mt-8 shadow-sm" :src="window.LINKS.phase2BioBrick.url" />
                    <div class="legendColiKaze textContent text-center italic mt-2">
                        Figure 1: Native MccPDI gene cluster found in E. coli 25
                    </div>
                    <div class="textContent mt-8 p-4">
                        <p>
                            The fact that MccPDI targets pathogenic strains as well as Biosafety Level 1 lab strains of
                            <i>E. coli</i> is <b>ideal for our proof of concept</b> as it will allow us to test and
                            validate its activity on <i>E. coli</i> K12 or B without posing any safety risks.
                        </p>
                    </div>
                    <div class="flex gap-4 mt-8 items-center textContent">
                        <div class="iconGoalMission"><i data-feather="crosshair"></i></div>
                        <div class="">
                            <p>Goal for phase 2</p>
                        </div>
                    </div>
                    <div class="textContent mt-8 p-4">
                        <div class="flex text-center mb-16 justify-start">
                            <div class="targetText p-2 pl-4 pr-4">
                                Express the microcin PDI gene cluster in order to achieve secretion of microcin PDI by
                                <i>E. coli</i> and show that its activity against the target cell is maintained.
                            </div>
                        </div>
                    </div>
                </div>
                <div id="achieve">
                    <div class="container">
                        <div class="titleAchieve flex items-center gap-4">
                            <div class="titleAchieveIcon rounded-full flex items-center justify-center">
                                <i data-feather="edit"></i>
                            </div>
                            <div class="titleAchieveText">How to achieve it?</div>
                        </div>
                        <div class="mt-6 textContent achieveText p-3">
                            <p>
                                The proximity dependent inhibition characteristic of the microcin we will be using is
                                still under investigation. Since it is currently thought that the
                                <b>inhibition is linked to a concentration</b> of microcin, our goal is to try to
                                respect the concentration initially produced by the <i>E. coli</i> 25 strain for this
                                proof of concept. However, the MccPDI gene cluster originally found in <i>E. coli</i> 25
                                is not constitutive and is
                                <b>controlled by the EnvZ/OmpR Two Component System</b> (TCS). In fact, knockout mutants
                                of the TCS did not show a PDI+phenotype<sup>5</sup>. EnvZ is an osmotic sensor which
                                upregulates the phosphorylation of OmpR (a transcription factor) which binds to the
                                promoter region upstream of McpM, McpI and McpA. It was shown that the production of
                                <b>MccPDI was higher in M9 medium</b>
                                compared to LB medium. Furthermore, mcpD and mcpB are under the influence of another
                                transcriptional regulation.
                            </p>
                            <br />
                            <p>
                                For our proof of concept, we had
                                <b>two options</b>:
                            </p>
                            <p>
                                - Clone the whole MccPDI cluster as it initially exists with its transcriptional
                                regulation properties
                            </p>
                            <p>
                                - Only use the coding sequences of each one of the 5 genes and choose our own promoters,
                                ribosome binding sites (RBS) and terminators
                            </p>

                            <p>
                                Overall the available data on the non-coding sequences found in the original MccPDI gene
                                cluster was not sufficient so we opted for <b>option number 2</b>.
                            </p>
                            <br />
                        </div>
                        <div class="mt-6 textContent achieveText p-3">
                            <p>
                                We were lucky to have the opportunity to exchange with
                                <b>Dr. Douglas Call</b> (Regents Professor of Molecular Epidemiology, Associate Director
                                for Research and Graduate Education, Allen School), who has previously published a few
                                articles on MccPDI<sup>6</sup>. When explaining our strategy to Dr. Call he suggested we
                                should be careful to <b>maintain molar equivalents</b> of McpM and McpI. This gave us
                                the idea to use the <b>Salis Lab RBS Calculator</b><sup>7</sup> to predict the
                                <b>Translation Initiation Rates</b> (TIRs) of the start codons of each of the 5 genes
                                contained in the native cluster.
                            </p>
                        </div>
                        <img x-data="{}" class="imgColiKaze mt-8 shadow-sm" :src="window.LINKS.phase2Board.url" />
                        <div class="legendColiKaze textContent text-center italic mt-2">
                            Figure 2: Comparison of the TIR of our construct with the native MccPDI cluster using the
                            Salis Lab RBS Calculator
                        </div>
                        <div class="mt-6 textContent achieveText p-3">
                            <p>
                                After this, the objective is to design our construct with the appropriate promoters and
                                RBS as to respect the native TIRs. We chose to maintain the expression of
                                <i>mcpM</i>, <i>mcpI</i> and <i>mcpA</i> under the control of the same promoter and
                                <i>mcpD</i> and <i>mcpB</i> under the control of another one.
                            </p>
                        </div>
                        <img x-data="{}" class="imgColiKaze mt-8 shadow-sm" :src="window.LINKS.phase2BioBrick2.url" />
                        <div class="legendColiKaze textContent text-center italic mt-2">
                            Figure 3: Our constructs for the expression and secretion of McpM
                        </div>
                        <div class="flex gap-4 mt-8 items-center textContent">
                            <div class="iconGoalMission"><i data-feather="help-circle"></i></div>
                            <div class="">
                                <p>How to validate our system?</p>
                            </div>
                        </div>
                        <div class="mt-6 textContent achieveText p-3">
                            <p>
                                In order to validate our system, we will perform an Agar Diffusion Assay. This will
                                confirm the proper secretion of McpM as well as its lytic activity on the target. For
                                this, a sensitive strain is plated (<i>E. coli</i> DH5Î± or BL21) and disks are
                                inoculated with different bacterial cultures. The positive control is
                                <i>E. coli</i> DH10B containing the native and functional MccPDI gene cluster in a
                                plasmid, kindly provided by Mr. Call. We should see a zone of inhibition around the disk
                                as the microcin is secreted and kills the surrounding cells. This control will be
                                compared to our engineered bacteria: <i>E. coli</i> DH5Î± containing the reconstructed
                                MccPDI cluster. The negative control is plating the dish with <i>E. coli</i> Î”OmpF which
                                is known to resist against the Microcinâ€™s action thanks to its mutation.
                            </p>
                            <img
                                x-data="{}"
                                class="imgColiKaze mt-8 shadow-sm"
                                :src="window.LINKS.phase2AgarDiffusion.url"
                            />
                            <div class="figureAnnotation">
                                Figure. 4: Agar Diffusion Assay to validate the proper secretion and activity of
                                Microcin PDI
                                <div class="figureAnnotationText">
                                    On the left is the positive control, where the plated bacteria are sensitive to
                                    Microcin PDI. On the right is the negative control, where the bacteria have a
                                    mutation in OmpF and are not affected but Microcin PDI. Figure created with
                                    BioRender.com.
                                </div>
                            </div>
                            <p>
                                To go further in the possible validation methods, we could combine phase 1 and 2 dans
                                see the different inhibition patterns according to the presence or absence of the LTF
                                which allows to localize the engineered bacteria in proximity of its target.
                            </p>
                        </div>
                    </div>
                </div>
                <div id="results">
                    <div class="titleAchieve flex items-center gap-4">
                        <div class="titleAchieveIcon rounded-full flex items-center justify-center">
                            <i data-feather="edit"></i>
                        </div>
                        <div class="titleAchieveText">Results</div>
                    </div>
                    <div class="flex gap-4 mt-8 items-center textContent">
                        <a x-data="{}" class="buttonLink" :href="window.ROOT_URL + '/Results'">Check Results</a>
                    </div>
                </div>
                <div id="perspectives">
                    <div class="titleAchieve flex items-center gap-4">
                        <div class="titleAchieveIcon rounded-full flex items-center justify-center">
                            <i data-feather="edit"></i>
                        </div>
                        <div class="titleAchieveText">Perspectives</div>
                    </div>
                    <div class="flex gap-4 mt-8 items-center textContent">
                        <div class="iconGoalMission"><i data-feather="database"></i></div>
                        <div class="">
                            <p>
                                As mentioned in phase 1, we are developing a <b>software</b> that will design the
                                BioBrick with the key LTF gene part according to the target. Since the overall project
                                aims at killing the target, we could look into <b>integrating an AMP database</b> to the
                                software as well if keep this killing method in the future. The goal is to have a
                                tailor-made system that can be easily modified according to the target bacterium. With
                                this in mind, we came across an article published by Geldart et al.<sup>8</sup> in 2016
                                containing preliminary data on a <b>microcin secretion system</b> which could be
                                <b>universal</b>. This means that the secretion system would always be the same (the
                                microcin V system) and only the coding sequence of the AMP would have to be replaced.
                                Furthermore, certain bacteriocins have been identified to <b>fight against biofilms</b>.
                                For example, <b>Microcin S</b> initially produced by probiotic strain
                                <i>E. coli</i> G3/10 manages to inhibit the adherence of enteropathogenic strains of
                                <i>E. coli</i><sup>9</sup>. Since antibiotic strains tend to increase their resistance
                                and survive by forming biofilms, it would be interesting to <b>combine</b> the secretion
                                of AMPs to this type of bacteriocin. A limit regarding bacteriocins is that some
                                resistance can occur when there is a continuous exposure. For example, it was shown that
                                a degrading enzyme exists for one of the most famous bacteriocins called Nisin
                                (nisinase).
                            </p>
                        </div>
                    </div>
                    <div class="flex gap-4 mt-8 items-center textContent">
                        <div class="iconGoalMission"><i data-feather="activity"></i></div>
                        <div class="">
                            <p>
                                This issue can be solved by
                                <b>secreting a few AMPs at a time</b>. Indeed, we found a study showing that resistance
                                to individual colicins occurs after 9 hours of treatment but when
                                <b>5 colicins are combined</b>, no resistance occurs<sup>10</sup>. Thus, the next step
                                of this phase would be to manage to secrete at least 3 antimicrobial peptides at a time
                                but maintain the specificity of our system. As AMPs are very sensitive to proteolytic
                                enzymes, <b>oral administration</b> often results in peptide degradation. It is
                                necessary to find a way to administer the bacteria to the site of infection which is
                                most of the time found inside the <b>Gastrointestinal Tract</b>. This is the
                                <b>fourth phase</b> of the project which will be discussed further on.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
        <div id="references" class="mt-16">
            <div class="container">
                <hr />
                <div class="mt-8 mb-8 textContent">
                    [1] Vinga, I., Baptista, C., Auzat, I., Petipas, I., Lurz, R., Tavares, P., Santos, M. A., &
                    SÃ£o-JosÃ©, C. (2012). Role of bacteriophage SPP1 tail spike protein gp21 on host cell receptor
                    binding and trigger of phage DNA ejection. Molecular Microbiology, 83(2), 289â€“303.<br />
                    https://doi.org/10.1111/j.1365-2958.2011.07931.x<br /><br />

                    [2] Trojet, S. N., Caumont-Sarcos, A., Perrody, E., Comeau, A. M., & Krisch, H. M. (2011). The gp38
                    adhesins of the T4 superfamily: A complex modular determinant of the Phageâ€™s host specificity.
                    Genome Biology and Evolution, 3(1), 674â€“686.<br />
                    https://doi.org/10.1093/gbe/evr059<br /><br />

                    [3] Tkhilaishvili, T., Winkler, T., MÃ¼ller, M., Perka, C., & Trampuz, A. (2020). Bacteriophages as
                    Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by
                    Multidrug-Resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 64(1).<br />
                    https://doi.org/10.1128/AAC.00924-19<br /><br />

                    [4] Kuipers, S., Ruth, M. M., Mientjes, M., de SÃ©vaux, R. G. L., & van Ingen, J. (2020). A Dutch
                    case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages
                    in a renal transplant patient. Antimicrobial Agents and Chemotherapy, 64(1).<br />
                    https://doi.org/10.1128/AAC.01281-19<br /><br />

                    [5]Comeau, A. M., TÃ©tart, F., Trojet, S. N., PrÃ¨re, M.-F., & Krisch, H. M. (2007). Phage-Antibiotic
                    Synergy (PAS): Î²-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth. PLoS ONE, 2(8),
                    e799.<br />
                    https://doi.org/10.1371/journal.pone.0000799<br /><br />

                    [6] Dunne, M., & Loessner, M. J. (2019). Modified Bacteriophage Tail Fiber Proteins for Labeling,
                    Immobilization, Capture, and Detection of Bacteria. In Methods in Molecular Biology (Vol. 1918, pp.
                    67â€“86). Humana Press Inc.<br />
                    https://doi.org/10.1007/978-1-4939-9000-9_6<br /><br />

                    [7] Islam, M. Z., Fokine, A., Mahalingam, M., Zhang, Z., Garcia-Doval, C., Van Raaij, M. J.,
                    Rossmann, M. G., & Rao, V. B. (2019). Molecular Anatomy of the Receptor Binding Module of a
                    Bacteriophage Long Tail Fiber. PLoS Pathogens, 15(12), 1â€“21.<br />
                    https://doi.org/10.1371/journal.ppat.1008193<br /><br />

                    [8] Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M.,
                    Wanner, B. L., & Mori, H. (2006). Construction of Escherichia coli K-12 in-frame, single-gene
                    knockout mutants: The Keio collection. Molecular Systems Biology, 2.<br />
                    https://doi.org/10.1038/msb4100050<br /><br />

                    [9] Strauss, J., Burnham, N. A., & Camesano, T. A. (2009). Atomic force microscopy study of the role
                    of LPS O-antigen on adhesion of E. coli. Journal of Molecular Recognition, 22(5), 347â€“355.<br />
                    https://doi.org/10.1002/jmr.955<br /><br />

                    [10] Yoichi, M., Abe, M., Miyanaga, K., Unno, H., & Tanji, Y. (2005). Alteration of tail fiber
                    protein gp38 enables T2 phage to infect Escherichia coli O157:H7. Journal of Biotechnology, 115(1),
                    101â€“107.<br />
                    https://doi.org/10.1016/j.jbiotec.2004.08.003
                </div>
            </div>
        </div>
        <footer></footer>
    </body>
    <style>
        html,
        body {
            background-color: #fafafa !important;
        }

        #phase3 h1 {
            display: none;
        }

        #phase3 {
            display: flex;
            flex-direction: column;
            justify-content: center;
            min-height: 80vh;
            background-repeat: no-repeat;
            background-position: top -80px right -80px;
            background-size: auto 100%;
        }

        .phase3Content {
            width: 100%;
            display: flex;
            justify-content: flex-start;
            flex-wrap: wrap;
            gap: 20px;
        }

        .phase3Text {
            display: flex;
            flex-direction: column;
            align-items: flex-start;
            justify-content: center;
            text-transform: uppercase;
            font-weight: 800;
            line-height: 1;
        }

        @keyframes phase3 {
            0% {
                position: relative;
                top: 200px;
                opacity: 0;
            }

            50% {
                position: relative;
                top: 200px;
                opacity: 0;
            }

            100% {
                position: relative;
                top: 0px;
            }
        }

        .phase3Text2 {
            color: #8d1f24;
            font-size: 30px;
            text-shadow: 0px 10px 20px rgba(141, 31, 37, 0.3);
            animation: phase3 2s;
        }

        @keyframes phase1 {
            0% {
                position: relative;
                left: 100px;
                opacity: 0;
            }

            100% {
                position: relative;
                left: 0px;
            }
        }

        .phase3Text1 {
            color: #e73327;
            text-shadow: 0px 10px 20px rgba(251, 31, 29, 0.2);
            font-size: 70px;
            animation: phase3 1s;
        }

        /* INTRODUCTION */

        #introduction {
            margin: 120px 0;
        }

        .userProfileImage {
            background-color: rgba(0, 0, 0, 0.05);
            height: 80px;
            width: 80px;
        }

        .userProfileImageSrc {
            background-color: rgb(255, 255, 255);
            height: 60px;
            width: 60px;
            background-position: center;
            background-size: cover;
        }

        .introductionTitle {
            color: #8d1f24;
            font-size: 25px;
            font-weight: 800;
        }

        .cardIntroduction {
            background-color: white;
            font-size: 15px;
            border-radius: 15px;
            max-width: 800px;
        }

        .emphase {
            color: #8d1f24;
            font-weight: 800;
        }

        .textContent {
            max-width: 900px;
            font-size: 15px;
        }

        /* FOCUS */

        #focus {
            margin-top: 100px;
        }

        .focusTitle {
            color: #8d1f24;
            font-size: 20px;
            font-weight: 800;
            margin-top: 30px;
        }

        .textFocus {
            font-weight: 800;
            display: flex;
            flex-direction: column;
            line-height: 1;
            gap: 10px;
            justify-content: center;
            margin-top: 100px;
        }

        .textFocus1Goal {
            color: #8d1f24;
            /* text-transform: uppercase; */
            font-size: 30px;
            display: flex;
            gap: 15px;
            align-items: center;
        }

        .textFocus1GoalIconWrapper {
            display: flex;
            justify-content: center;
            align-items: center;
            height: 40px;
            width: 40px;
            background-color: rgba(231, 52, 39, 0.2);
            border-radius: 999px;
        }

        .targetText {
            background-color: rgba(231, 52, 39, 0.1);
            border-radius: 15px;
        }

        .focusContent {
            margin-top: 40px;
        }

        .focusContent > p {
            margin-bottom: 20px;
        }

        .focusContent > p:last-child {
            margin-bottom: 0;
        }

        /* GOALS */

        #goals {
            margin-top: 120px;
        }

        .titleGoal {
            color: #8d1f24;
        }

        .titleGoalIcon {
            background-color: rgba(231, 52, 39, 0.2);
            height: 40px;
            width: 40px;
        }

        .titleGoalText {
            /* text-transform: uppercase; */
            font-weight: 800;
            font-size: 30px;
        }

        .goalFocus {
            background-color: white;
            border-radius: 15px;
            font-size: 15px;
        }

        .iconGoalMission > svg {
            height: 80px;
            width: 40px;
        }

        .goalsParameterCard {
            background-color: white;
            max-width: 380px;
            flex-grow: 1;
            border-radius: 15px;
            font-size: 15px;
            overflow: hidden;
        }

        .goalsParameterCardTitle {
            font-size: 20px;
            font-weight: 800;
        }

        .goalsParameterCardText {
            background-color: #fcfcfc;
            border-top: 1px solid rgba(0, 0, 0, 0.03);
        }

        .imgColiKaze {
            max-width: 900px;
            width: 100%;
            background-color: white;
            border-radius: 15px;
            padding: 10px 10px;
        }

        @keyframes switchLineAnim {
            0% {
                background-color: #d7d7d7;
            }

            100% {
                background-color: #8d1f24;
            }
        }

        @keyframes switchButtonAnim {
            0% {
                left: 0;
            }

            100% {
                left: 25px;
            }
        }

        @keyframes switchButtonInsideAnim {
            0% {
                background-color: #e9e9e9;
            }

            100% {
                background-color: #e73327;
            }
        }

        .switch {
            position: relative;
        }

        .switch.active .switchLine {
            background-color: #8d1f24;
            animation: switchLineAnim 0.7s;
        }

        .switchLine {
            width: 80px;
            height: 14px;
            background-color: #d7d7d7;
            border-radius: 999px;
            position: relative;
            z-index: 2;
        }

        .switch.active .switchButton {
            left: 25px;
            animation: switchButtonAnim 0.7s;
        }

        .switchButton {
            height: 56px;
            width: 56px;
            background-color: white;
            border-radius: 999px;
            position: absolute;
            top: -21px;
            left: 0;
            display: flex;
            justify-content: center;
            align-items: center;
            border: 1px solid rgba(0, 0, 0, 0.03);
            z-index: 3;
        }

        .switch.active .switchButtonInside {
            background-color: #e73327;
            animation: switchButtonInsideAnim 0.7s;
        }

        .switchButtonInside {
            height: 21px;
            width: 21px;
            background-color: #e9e9e9;
            border-radius: 999px;
        }

        @keyframes switchBackAnim {
            0% {
                height: 0px;
                width: 0px;
                opacity: 0.3;
            }
            50% {
                height: 200px;
                width: 200px;
                opacity: 0;
            }
            100% {
                height: 200px;
                width: 200px;
                opacity: 0;
            }
        }

        .switchBack {
            border-radius: 999px;
            background-color: #8d1f24;
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            height: 300px;
            width: 300px;
            z-index: 1;
            opacity: 0;
        }

        .switch.active .switchBack {
            animation: switchBackAnim 4s infinite;
        }

        .goalsParameterImgSkull {
            height: 100px;
        }

        /* ACHIEVE */

        #achieve {
            margin-top: 120px;
        }

        .titleAchieve {
            color: #8d1f24;
        }

        .titleAchieveIcon {
            background-color: rgba(231, 52, 39, 0.2);
            height: 40px;
            width: 40px;
        }

        .titleAchieveText {
            /* text-transform: uppercase; */
            font-weight: 800;
            font-size: 30px;
        }

        .schema2 {
            border-radius: 15px;
            max-width: 900px;
            padding: 0 50px;
            background-color: white;
            width: 100%;
        }

        .schema2anotation {
            max-width: 900px;
            font-size: 12px;
        }

        .achieveText > p {
            margin-bottom: 20px;
        }

        .achieveText > p:last-child {
            margin-bottom: 0;
        }

        #results {
            margin-top: 120px;
        }

        #perspectives {
            margin-top: 120px;
        }

        .taglines {
            display: flex;
            flex-direction: row;
            justify-content: center;
            flex-wrap: wrap;
            gap: 40px;
        }

        .taglines > div {
            background-color: white;
            border-radius: 10px;
            height: 200px;
            width: 200px;
            display: flex;
            justify-content: center;
            align-items: center;
            padding: 20px;
            -webkit-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            -moz-box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            box-shadow: 0px 5px 10px 0px rgba(0, 0, 0, 0.03);
            color: rgb(32, 32, 32);
            font-style: 20px;
            font-weight: 800;
            overflow: hidden;
            position: relative;
        }

        .taglineLineLine {
            background-color: #8d1f24;
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 6px;
        }

        /* REFERENCES */

        #references div {
            font-size: 10px;
        }

        .textBubble {
            margin: 20px;
            display: flex;
            line-height: 1;
            gap: 10px;
        }

        .textBubble1 {
            color: rgba(0, 0, 0, 0.8);
            font-size: 15px;
            display: flex;
            gap: 15px;
            align-items: center;
        }

        .textBubbleIconWrapper {
            display: flex;
            color: #e73327;
            justify-content: center;
            align-items: center;
            height: 80px;
            width: 80px;
            background-color: rgba(231, 52, 39, 0.2);
            border-radius: 999px;
        }
        .figureAnnotation {
            margin: 20px 0 80px 0;
            text-align: center;
            font-style: italic;
        }

        .figureAnnotationText {
            font-size: 13px;
            color: rgba(0, 0, 0, 0.6);
            text-align: left;
        }

        .buttonLink {
            background-color: rgba(0, 0, 0, 0.02) !important;
            border-radius: 5px;
            display: inline-block;
            padding: 10px 20px;
            border: 1px solid rgba(0, 0, 0, 0.03);
            cursor: pointer;
            color: black !important;
            text-decoration: none;
            margin-top: 20px;
            margin-left: 50px;
        }

        .buttonLink:hover {
            background-color: rgba(0, 0, 0, 0.05) !important;
            color: black !important;
            text-decoration: none;
        }
    </style>
</html>
